Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization Insights From VOYAGER PAD

Abstract

BACKGROUND: Paclitaxel drug-coated devices (DCDs) were developed to improve lower extremity revascularization (LER) patency in peripheral artery disease (PAD) but have been associated with long-term mortality. OBJECTIVES: This study assessed DCD safety and effectiveness in LER for PAD.

Authors

Hess CN; Patel MR; Bauersachs RM; Anand SS; Debus ES; Nehler MR; Fanelli F; Yeh RW; Secemsky EA; Beckman JA

Journal

Journal of the American College of Cardiology, Vol. 78, No. 18, pp. 1768–1778

Publisher

Elsevier

Publication Date

November 2021

DOI

10.1016/j.jacc.2021.08.052

ISSN

0735-1097

Associated Experts

Sonia Anand

Professor, Faculty of Health Sciences

Visit profile

Labels